Many Biobanks are under pressure to adopt more sustainable, business-like mentalities in the future. The results of a ISBER survey on business planning in the Biobanking community is outlined in this post.
The Health Research Authority (HRA) have published new guidance on taking a proportionate approach to consent, particularly in reference to clinical trials.
Accreditation Review of the CCB’s pilot audit scheme Background Biobanking is recognised as a critical area requiring development if progress is to be made in identifying clinically useful markers of disease and disease progression, discovering new drug targets and understanding the mechanisms of disease in cancer. Researchers continue to report that they are unable to obtain sufficient high quality, well annotated samples of diseased and control tissue, blood and other… Read More »Accreditation
Access Template The access policy could be one of the most important documents that you as a Biobank will create as it will define so much of the interactions you are likely to have with researchers. Starting from scratch can be a daunting process, but luckily, the NCRI have created a template document. It sets out some of the key points you should include, as well as including some reference… Read More »Access Template
User Personas We have been undertaking a review of the different stakeholders in Biobanking to understand how different people may interact with our biobank directory. This work was undertaken by the user-experience team at the University of Nottingham and the outputs are below to be viewed. These are generalisations but useful for us to understand some of the key reasons why groups may (or may not) get involved with our… Read More »Personas